Financial Ratios Beauty Farm Medical and Health Industry Inc.
Stocks
2373
KYG0929L1041
Personal Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.00 HKD | -4.17% |
|
-2.91% | -37.50% |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | 7.03 | 3.41 | 5.8 | 5.1 | 6.06 | ||
Return on Total Capital | 22.44 | 11.25 | 15.82 | 12.46 | 13.88 | ||
Return On Equity % | 103.33 | 47.47 | 44.37 | 27.91 | 33.32 | ||
Return on Common Equity | 97.17 | 46.23 | 43.54 | 26.16 | 32.29 | ||
Margin Analysis | |||||||
Gross Profit Margin % | 46.82 | 43.89 | 45.55 | 46.26 | 49.05 | ||
SG&A Margin | 32.12 | 35.18 | 32.47 | 33.04 | 33.05 | ||
EBITDA Margin % | 20.01 | 14.79 | 18.01 | 17.51 | 20.11 | ||
EBITA Margin % | 15.01 | 9.1 | 13.13 | 12.85 | 15.83 | ||
EBIT Margin % | 14.46 | 8.29 | 12.54 | 12.02 | 15.06 | ||
Income From Continuing Operations Margin % | 11.7 | 6.76 | 10.73 | 9.82 | 11.34 | ||
Net Income Margin % | 10.86 | 6.3 | 10.05 | 8.88 | 10.58 | ||
Net Avail. For Common Margin % | 10.86 | 6.3 | 10.05 | 8.88 | 10.58 | ||
Normalized Net Income Margin | 7.39 | 4.05 | 7.06 | 6.44 | 8.43 | ||
Levered Free Cash Flow Margin | 28.25 | 12 | 20.32 | 41.47 | 25.58 | ||
Unlevered Free Cash Flow Margin | 29.1 | 12.94 | 21.05 | 42.13 | 26.25 | ||
Asset Turnover | |||||||
Asset Turnover | 0.78 | 0.66 | 0.74 | 0.68 | 0.64 | ||
Fixed Assets Turnover | 2.3 | 1.99 | 2.36 | 2.68 | 3.27 | ||
Receivables Turnover (Average Receivables) | 45.16 | 32.78 | 34.86 | 42.07 | 45.86 | ||
Inventory Turnover (Average Inventory) | 8.3 | 5.75 | 5.61 | 6.3 | 8.43 | ||
Short Term Liquidity | |||||||
Current Ratio | 0.71 | 0.65 | 0.94 | 0.8 | 0.98 | ||
Quick Ratio | 0.61 | 0.51 | 0.81 | 0.7 | 0.9 | ||
Operating Cash Flow to Current Liabilities | 0.36 | 0.2 | 0.3 | 0.29 | 0.34 | ||
Days Sales Outstanding (Average Receivables) | 8.08 | 11.13 | 10.47 | 8.7 | 7.96 | ||
Days Outstanding Inventory (Average Inventory) | 43.97 | 63.44 | 65.1 | 58.06 | 43.31 | ||
Average Days Payable Outstanding | 6.15 | 4.39 | 4.4 | 6.91 | 8.19 | ||
Cash Conversion Cycle (Average Days) | 45.9 | 70.19 | 71.17 | 59.85 | 43.08 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 196.34 | 258.73 | 67.5 | 74.91 | 121.32 | ||
Total Debt / Total Capital | 66.25 | 72.12 | 40.3 | 42.83 | 54.82 | ||
LT Debt/Equity | 134.18 | 184.4 | 47.2 | 50.29 | 93.29 | ||
Long-Term Debt / Total Capital | 45.28 | 51.4 | 28.18 | 28.75 | 42.15 | ||
Total Liabilities / Total Assets | 89.4 | 91.86 | 74.74 | 77.2 | 78.86 | ||
EBIT / Interest Expense | 10.63 | 5.49 | 10.84 | 11.22 | 14.05 | ||
EBITDA / Interest Expense | 21.9 | 17.37 | 24.05 | 24.91 | 26.43 | ||
(EBITDA - Capex) / Interest Expense | 16.4 | 11.68 | 17.63 | 20.77 | 24.35 | ||
Total Debt / EBITDA | 0.97 | 1.22 | 0.94 | 1.06 | 1.52 | ||
Net Debt / EBITDA | -1.07 | -0.9 | -1.69 | -1.6 | -1.47 | ||
Total Debt / (EBITDA - Capex) | 1.3 | 1.82 | 1.29 | 1.28 | 1.65 | ||
Net Debt / (EBITDA - Capex) | -1.43 | -1.33 | -2.31 | -1.92 | -1.59 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 18.46 | -8.16 | 31.16 | 19.91 | 16.65 | ||
Gross Profit, 1 Yr. Growth % | 19.11 | -13.91 | 36.12 | 21.79 | 23.69 | ||
EBITDA, 1 Yr. Growth % | 17.8 | -32.12 | 59.63 | 16.57 | 34 | ||
EBITA, 1 Yr. Growth % | 25.92 | -44.32 | 89.1 | 17.35 | 43.64 | ||
EBIT, 1 Yr. Growth % | 26.26 | -47.36 | 98.17 | 14.97 | 46.09 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 36.9 | -46.95 | 108.21 | 9.71 | 34.77 | ||
Net Income, 1 Yr. Growth % | 28.16 | -46.71 | 109.15 | 5.94 | 39 | ||
Normalized Net Income, 1 Yr. Growth % | 19.15 | -49.61 | 128.36 | 9.48 | 52.59 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | 28.16 | -46.79 | 82.26 | 5.32 | 38.38 | ||
Accounts Receivable, 1 Yr. Growth % | 14.89 | 36.62 | 13.61 | -13.13 | 30.16 | ||
Inventory, 1 Yr. Growth % | 41.63 | 38.49 | 24.92 | -10.46 | -24.89 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.12 | 9.42 | 10.98 | 1.04 | -9.65 | ||
Total Assets, 1 Yr. Growth % | 17.79 | 0.73 | 32.32 | 29.51 | 18 | ||
Tangible Book Value, 1 Yr. Growth % | -78.36 | 234.42 | -655.29 | -111.78 | -54.93 | ||
Common Equity, 1 Yr. Growth % | 82.69 | -26.66 | 324.85 | 17.8 | 8.19 | ||
Cash From Operations, 1 Yr. Growth % | -1.56 | -42.98 | 63.75 | 27.36 | 25.42 | ||
Capital Expenditures, 1 Yr. Growth % | 97.27 | 5.72 | 13.1 | -28.29 | -41.25 | ||
Levered Free Cash Flow, 1 Yr. Growth % | -10.8 | -61 | 122.12 | 144.64 | -28.03 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | -10.68 | -59.16 | 113.24 | 140.05 | -27.31 | ||
Dividend Per Share, 1 Yr. Growth % | - | - | 24.65 | 12.51 | 28.93 | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 12.59 | 4.3 | 9.75 | 25.41 | 18.27 | ||
Gross Profit, 2 Yr. CAGR % | 8.49 | 1.26 | 8.25 | 28.75 | 22.73 | ||
EBITDA, 2 Yr. CAGR % | 12.87 | -10.58 | 4.13 | 36.42 | 24.98 | ||
EBITA, 2 Yr. CAGR % | 13.14 | -16.27 | 2.67 | 48.97 | 29.83 | ||
EBIT, 2 Yr. CAGR % | 13.18 | -18.47 | 2.21 | 50.94 | 29.6 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 18.88 | -14.78 | 5.1 | 51.14 | 21.6 | ||
Net Income, 2 Yr. CAGR % | 17.42 | -17.35 | 5.58 | 48.85 | 21.35 | ||
Normalized Net Income, 2 Yr. CAGR % | 13.46 | -22.52 | 7.27 | 58.11 | 29.25 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | 17.42 | -17.42 | -1.52 | 38.55 | 20.72 | ||
Accounts Receivable, 2 Yr. CAGR % | 17.93 | 25.29 | 24.58 | -0.66 | 6.34 | ||
Inventory, 2 Yr. CAGR % | 4.93 | 40.06 | 31.53 | 5.76 | -17.99 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | -4.38 | 6.23 | 10.2 | 5.89 | -4.45 | ||
Total Assets, 2 Yr. CAGR % | 16.71 | 8.93 | 15.45 | 30.91 | 23.62 | ||
Tangible Book Value, 2 Yr. CAGR % | -61.5 | -14.93 | 330.93 | -19.11 | -76.96 | ||
Common Equity, 2 Yr. CAGR % | 133.17 | 15.75 | 76.52 | 123.71 | 12.89 | ||
Cash From Operations, 2 Yr. CAGR % | 20.25 | -25.08 | -3.37 | 44.41 | 26.38 | ||
Capital Expenditures, 2 Yr. CAGR % | 11.13 | 44.42 | 9.35 | -9.94 | -35.1 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | -41.02 | -6.91 | 133.11 | 32.69 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | -39.61 | -6.66 | 126.25 | 32.09 | ||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 17.96 | 21.52 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 5.2 | 12.58 | 13.04 | 22.42 | ||
Gross Profit, 3 Yr. CAGR % | - | 0.45 | 11.76 | 12.59 | 27.04 | ||
EBITDA, 3 Yr. CAGR % | - | -4.73 | 8.5 | 8.13 | 35.61 | ||
EBITA, 3 Yr. CAGR % | - | -10.68 | 9.9 | 7.35 | 47.17 | ||
EBIT, 3 Yr. CAGR % | - | -12.31 | 9.67 | 6.3 | 49.31 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | -9.15 | 14.78 | 6.61 | 45.47 | ||
Net Income, 3 Yr. CAGR % | - | -9.76 | 12.62 | 5.7 | 45.49 | ||
Normalized Net Income, 3 Yr. CAGR % | - | -13.44 | 11.09 | 8 | 56.25 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | -9.81 | 7.52 | 0.71 | 38.49 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 23.86 | 21.27 | 10.47 | 8.71 | ||
Inventory, 3 Yr. CAGR % | - | 15.1 | 34.82 | 15.71 | -5.64 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 0.02 | 7.79 | 7.06 | 0.44 | ||
Total Assets, 3 Yr. CAGR % | - | 11.12 | 16.23 | 19.96 | 26.46 | ||
Tangible Book Value, 3 Yr. CAGR % | - | -20.86 | 58.98 | 29.83 | -33.44 | ||
Common Equity, 3 Yr. CAGR % | - | 58.57 | 78.55 | 54.26 | 75.6 | ||
Cash From Operations, 3 Yr. CAGR % | - | -6.23 | -2.77 | 5.94 | 37.78 | ||
Capital Expenditures, 3 Yr. CAGR % | - | 9.3 | 33.12 | -5 | -21.9 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | -8.22 | 28.47 | 57.55 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | -8.02 | 27.88 | 54.95 | ||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | 22.23 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 12.86 | 14.82 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 10.93 | 16.03 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 10 | 14.82 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 9.63 | 17.48 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 9 | 17.24 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 11.36 | 17.46 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 10.24 | 16.04 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 10.15 | 18.02 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | 7.09 | 12.62 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 13.4 | 15.06 | ||
Inventory, 5 Yr. CAGR % | - | - | - | 11.27 | 10.51 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 2.33 | 2.71 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 18.65 | 19.13 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | -20.17 | -26.58 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 81.97 | 48.64 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 11.45 | 7.98 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 1.15 | -0.13 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 6.36 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 6.31 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















